Delisting riskPopularity #3,534
BIAF · NASDAQ · Medical - Diagnostics & Research

bioAffinity Technologies (BIAF)

Runs a pathology laboratory and sells a sputum-based lung-cancer assessment test.

$8.50
After hours−0.09 (−1.05%)
At close$8.59(+11.56%)